cisapride has been researched along with Syndrome in 9 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double-blind, placebo-controlled, crossover trial, we investigated the effects of the prokinetic drug cisapride in patients with cystic fibrosis and chronic recurrent distal intestinal obstruction syndrome (DIOS)." | 9.06 | Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome. ( Corey, M; Durie, PR; Ellis, L; Koletzko, S; Spino, M; Stringer, DA, 1990) |
| "The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome)." | 7.70 | Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. ( Pasternak, RE; Ranen, NG; Rovner, BW, 1999) |
| "with cisapride long-lasting symptomatic relief and improved transit is achieved in about 40% of patients with the Roux-en-Y syndrome." | 7.68 | Cisapride in treatment of Roux-en-Y syndrome. ( Beekhuis, H; Bleichrodt, RP; Kleibeuker, JH; van der Mijle, HC, 1991) |
| "In a double-blind, placebo-controlled, crossover trial, we investigated the effects of the prokinetic drug cisapride in patients with cystic fibrosis and chronic recurrent distal intestinal obstruction syndrome (DIOS)." | 5.06 | Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome. ( Corey, M; Durie, PR; Ellis, L; Koletzko, S; Spino, M; Stringer, DA, 1990) |
| "The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome)." | 3.70 | Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. ( Pasternak, RE; Ranen, NG; Rovner, BW, 1999) |
| "with cisapride long-lasting symptomatic relief and improved transit is achieved in about 40% of patients with the Roux-en-Y syndrome." | 3.68 | Cisapride in treatment of Roux-en-Y syndrome. ( Beekhuis, H; Bleichrodt, RP; Kleibeuker, JH; van der Mijle, HC, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, J | 1 |
| Gilchrist, FJ | 1 |
| Carroll, W | 1 |
| Poncet, CM | 1 |
| Dupre, GP | 1 |
| Freiche, VG | 1 |
| Bouvy, BM | 1 |
| Sheptulin, AA | 1 |
| Corrado, G | 1 |
| D'Eufemia, P | 1 |
| Pacchiarotti, C | 1 |
| Cavaliere, M | 1 |
| Rea, P | 1 |
| Frandina, G | 1 |
| Giardini, O | 1 |
| Cardi, E | 1 |
| Ranen, NG | 1 |
| Pasternak, RE | 1 |
| Rovner, BW | 1 |
| van der Mijle, HC | 1 |
| Beekhuis, H | 1 |
| Bleichrodt, RP | 1 |
| Kleibeuker, JH | 1 |
| Annerén, G | 1 |
| Meurling, S | 1 |
| Olsen, L | 1 |
| Bourhis, F | 1 |
| Rolachon, A | 1 |
| Bost, R | 1 |
| Rais, A | 1 |
| Hostein, J | 1 |
| Koletzko, S | 1 |
| Corey, M | 1 |
| Ellis, L | 1 |
| Spino, M | 1 |
| Stringer, DA | 1 |
| Durie, PR | 1 |
3 reviews available for cisapride and Syndrome
| Article | Year |
|---|---|
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
Topics: Adolescent; Adult; Cisapride; Cystic Fibrosis; Gastrointestinal Agents; Humans; Intestinal Obstructi | 2018 |
[Current concepts concerning functional dyspepsia syndrome].
Topics: Antacids; Anti-Ulcer Agents; Cisapride; Diagnosis, Differential; Dopamine Antagonists; Dyspepsia; Hi | 1995 |
Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS), an autosomal recessive disorder: clinical reports and review of the literature.
Topics: Abnormalities, Multiple; Cisapride; Colon; Consanguinity; Female; Genes, Lethal; Genes, Recessive; H | 1991 |
1 trial available for cisapride and Syndrome
| Article | Year |
|---|---|
Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome.
Topics: Adolescent; Adult; Chronic Disease; Cisapride; Cystic Fibrosis; Double-Blind Method; Female; Humans; | 1990 |
5 other studies available for cisapride and Syndrome
| Article | Year |
|---|---|
Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs.
Topics: Airway Obstruction; Analysis of Variance; Animals; Anti-Ulcer Agents; Cisapride; Dog Diseases; Dogs; | 2006 |
Irritable oesophagus syndrome as cause of chronic cough.
Topics: Chronic Disease; Cisapride; Cough; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Hydrogen-Io | 1996 |
Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.
Topics: Aged; Cisapride; Female; Hallucinations; Humans; Male; Serotonin Receptor Agonists; Syndrome; Vision | 1999 |
Cisapride in treatment of Roux-en-Y syndrome.
Topics: Adult; Aged; Anastomosis, Roux-en-Y; Cisapride; Female; Gastric Emptying; Humans; Jejunum; Male; Mid | 1991 |
[Acute colonic pseudo-obstruction (Ogilvie's syndrome): treatment with cisapride].
Topics: Acute Disease; Adult; Cisapride; Colonic Pseudo-Obstruction; Humans; Male; Piperidines; Serotonin An | 1991 |